Your shopping cart is currently empty

M464 is a potent and orally active non-steroidal anti-inflammatory compound functioning as an NLRP3 inflammasome inhibitor. It works by preventing ASC oligomerization and decreasing ROS production, thereby inhibiting pyroptosis and blocking the expression of downstream Caspase-1 and the release of IL-1β. M464 demonstrates protective effects against acute lung and liver injury in mice and can be utilized in research on NLRP3-related inflammatory diseases.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | M464 is a potent and orally active non-steroidal anti-inflammatory compound functioning as an NLRP3 inflammasome inhibitor. It works by preventing ASC oligomerization and decreasing ROS production, thereby inhibiting pyroptosis and blocking the expression of downstream Caspase-1 and the release of IL-1β. M464 demonstrates protective effects against acute lung and liver injury in mice and can be utilized in research on NLRP3-related inflammatory diseases. |
| In vitro | M464, at concentrations of 3-12 μM, inhibits the expression of marker proteins associated with NLRP3 inflammasome activation, including IL-1β and Caspase-1, as well as suppresses the production of intracellular ROS and the formation of ASC oligomers in J774A.1 and THP-1 cells. Additionally, M464 (3-12 μM; 1 hour) prevents macrophage pyroptosis triggered by NLRP3 inflammasome stimuli in J774A.1 and THP-1 cells. |
| In vivo | Administered at doses of M464 (15, 30, 60 mg/kg; orally; 1 hour prior to LPS injection), the compound reduces LPS-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation. In the same dosage and administration manner, M464 also mitigates acute liver injury in mice triggered by LPS and D-GalN, again through the inhibition of NLRP3 inflammasome activation. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.